The Future of Technology Procurement in Social Care: From Supplier Claims to Evidence-Based Investment

A provider can spend months selecting a digital care system, negotiate an apparently competitive contract and complete implementation on schedule, yet still struggle to answer the most important question: was the investment worthwhile for the people receiving support? The supplier may demonstrate faster recording, automated alerts and improved management visibility. Those capabilities matter, but they are not the same as evidence of safer care, greater independence or more consistent relationships.

This distinction is becoming central to digital transformation in adult social care. Technology is increasingly involved in care planning, medicines records, workforce scheduling, assistive support, quality monitoring and information sharing. Procurement decisions therefore influence everyday practice, organisational risk and the experiences of people who may have little direct involvement in choosing the systems used around them.

The opportunity is to move from buying promised functionality towards evidence-led digital procurement and contract management. This requires a different relationship with suppliers, clearer investment objectives and greater attention to whether the proposed technology fits the service. It also requires person-centred technology decisions that consider choice, accessibility, privacy and independence alongside operational efficiency.

For providers, Registered Managers, boards and commissioners, the central challenge is no longer simply identifying which technology is available. It is establishing what should be purchased, what evidence justifies the decision, who remains accountable and how benefits will be verified after implementation.

Why Technology Procurement Is Becoming a Strategic Care Decision

Digital procurement was once frequently treated as a relatively contained operational decision. A provider needed an electronic care planning system, a scheduling platform or a replacement for paper records. The purchasing process might focus on demonstrations, licence costs, technical specifications and whether staff could operate the product.

Those considerations remain necessary, but the consequences of procurement now extend much further. Digital systems increasingly determine how information moves between teams, which risks attract management attention, how care workers record their observations and how senior leaders interpret service performance. A poorly chosen system can introduce additional administrative work, fragmented records or dependence on a supplier whose commercial priorities differ from the provider's responsibilities.

Conversely, a well-selected system can reduce avoidable duplication, improve communication, make changes in people's needs more visible and give managers better evidence for intervention. Its value depends on the service model, workforce capability, data quality and the arrangements surrounding implementation.

This is particularly important for smaller providers operating within constrained fee arrangements. A product that appears affordable on a monthly subscription may become expensive once training, migration, integration, additional devices, support and contract termination are considered. Larger organisations face different challenges, including inconsistent systems across services, complex procurement governance and the risk of introducing technology that works centrally but poorly in individual locations.

Technology purchasing therefore belongs within organisational strategy and risk management rather than being delegated entirely to an IT function. The decision should connect operational requirements with quality objectives, financial sustainability, workforce practice and the lived experiences of people receiving support.

From Supplier Claims to Testable Investment Propositions

Supplier demonstrations are designed to communicate product strengths. They may show streamlined workflows, impressive dashboards, reduced administration or sophisticated artificial intelligence. However, demonstrations typically take place in controlled conditions, using prepared data and processes that may not resemble the complexity of an adult social care service.

A claim that a platform reduces recording time by 30% raises several legitimate questions. What was the starting point? Which tasks were measured? Were staff already familiar with the product? Did the calculation include correcting errors, supervision, management review and additional work elsewhere? Most importantly, did the time released translate into better support or merely a different distribution of administration?

Evidence-based procurement does not require providers to reject supplier claims. It requires claims to become propositions that can be tested against the organisation's own circumstances. A supplier's case study may demonstrate potential, but it should not be mistaken for proof that identical results will follow in another setting.

Before evaluating products, a provider can establish a baseline describing the problem it intends to address. For electronic records, that might include documentation quality, time spent retrieving information, delayed reviews, staff experience and the consequences of missing or inconsistent entries. For assistive technology, the baseline may concern independence, night-time disturbance, response to changes in need and the person's own assessment of whether support feels proportionate.

The provider can then identify a small set of measures that would constitute meaningful improvement. This approach connects procurement with data quality and performance measurement while avoiding the assumption that every measurable change represents a positive outcome.

A credible investment proposition also recognises uncertainty. Suppliers may provide evidence from comparable services, independent evaluations, reference customers or pilot results, but the strength and transferability of that evidence will vary. Providers should distinguish between demonstrated functionality, observed operational improvement and credible evidence of better outcomes for people.

Procurement Law, Public Commissioning and Provider Purchasing

Technology procurement takes place within different legal and commercial arrangements. An independent care provider purchasing a digital system for its own operations is not automatically subject to the public procurement regime simply because it delivers publicly funded care. Its obligations depend on its legal status, contractual commitments, funding conditions and the nature of the purchase.

For contracting authorities in England, the Procurement Act 2023 provides the principal framework for covered public procurements commenced under the new regime from 24 February 2025. Transitional arrangements mean that some earlier procurements continue under previous legislation. The Act's requirements, applicable thresholds, exemptions and procedural rules need to be considered in relation to the specific procurement.

The public procurement framework emphasises value for money, public benefit, transparency and integrity. These considerations are especially relevant when local authorities or NHS bodies purchase technology intended to support commissioned care, shared information systems or wider service transformation. Value for money should not be interpreted as selecting the lowest initial price without regard to quality, risk or long-term cost.

For providers, procurement processes and law also matter indirectly through commissioning specifications, contractual reporting requirements and expectations around digital compatibility. A provider may purchase its own technology but still need to demonstrate that it can meet information-sharing, security, safeguarding and performance requirements set by its commissioners.

Where a technology purchase is connected to a public service contract, the allocation of responsibilities should be explicit. A local authority may specify an outcome or reporting requirement without selecting the supplier. Alternatively, a commissioner may provide or mandate access to a particular system. These models create different responsibilities for implementation, training, data governance, support and continuity.

Commissioners should also consider whether digital requirements create unintended barriers for smaller providers, personal assistants or people using direct payments. A specification that assumes extensive digital infrastructure may impose costs that are not reflected in fees or may restrict participation without delivering proportionate benefits.

The strongest commissioning approach distinguishes the outcomes required from unnecessary prescriptions about how every provider should achieve them. This preserves room for innovation while allowing contracting authorities to evaluate whether proposed solutions are credible, accessible, secure and sustainable.

Regulatory Accountability Cannot Be Purchased from a Supplier

In England, CQC regulates registered providers against applicable legal requirements, including the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014. Relevant obligations include person-centred care, consent, safe care and treatment, safeguarding, staffing and good governance. Digital procurement can influence how effectively these responsibilities are discharged, but purchasing a particular product does not establish compliance.

Regulation 17, concerning good governance, is particularly relevant because providers need effective systems for assessing, monitoring and improving quality and safety, managing risks and maintaining accurate records. A digital platform may support these functions, but the provider remains responsible for whether its systems operate effectively.

For example, an electronic care record may make reviews easier to schedule. That does not establish whether reviews are meaningful, whether people's wishes have changed or whether staff act on identified risks. Similarly, an automated alert may improve visibility without ensuring that an appropriate person responds promptly.

CQC's assessment approach considers evidence across relevant quality statements and areas of practice. Technology may contribute to assurance concerning safe systems, person-centred care, monitoring outcomes, workforce competence and governance. Inspectors may consider records alongside conversations with people, staff experience, observations and evidence of improvement.

The distinction between product capability and actual practice is fundamental to CQC evidence and provider assurance. An organisation may hold a supplier's compliance statement, implementation certificate and extensive dashboard reports while still being unable to show that the technology supports safe, responsive care.

Registered Managers need sufficient visibility of how systems affect daily delivery. Directors and boards need assurance that significant procurement decisions have been properly evaluated and that implementation risks remain controlled. Technical expertise can be delegated, but regulatory and organisational accountability cannot simply be transferred to a software supplier.

Building a Whole-Life Business Case Rather Than Comparing Licence Prices

Initial price comparisons are often misleading because digital systems create costs and benefits throughout their operational life. A relatively inexpensive platform may require significant manual work to transfer information, have limited integration options or impose charges for additional reporting and support. A more expensive product may offer genuine efficiencies, but those benefits should be evidenced rather than assumed.

Whole-life appraisal considers the financial and operational consequences of selecting, implementing, operating and eventually replacing a system. It should include the cost of organisational disruption as well as the supplier's commercial terms.

Relevant considerations commonly include:

• Licensing, devices, connectivity, maintenance, upgrades and additional modules.
• Data migration, integration, configuration and independent technical assurance.
• Training, temporary productivity losses, supervision and workforce support.
• Cybersecurity, incident response, business continuity and supplier failure arrangements.
• Contract variations, data extraction, exit assistance and switching costs.
• Expected improvements in care quality, independence, continuity and operational capacity.

Not every benefit should be converted into a monetary saving. A technology that helps someone retain control over daily routines may have substantial value even if it does not reduce staffing costs. Equally, a claimed reduction in staff time should not automatically be treated as a cashable saving where safe staffing levels and continuity requirements remain unchanged.

Providers can use the Digital Transformation Readiness Assessment to structure an examination of strategic readiness, workforce capability, digital infrastructure and cyber resilience before committing to a significant purchase.

For boards, the investment decision becomes more credible when assumptions are visible. The business case should explain which benefits are expected, how confident the organisation is in those expectations, what could prevent delivery and when leaders will review whether the original case remains valid.

Scenario: A Homecare Provider Tests the Promise of Smarter Scheduling

A medium-sized domiciliary care provider is considering replacing its scheduling system. One supplier promises substantial reductions in travel time, fewer late visits and improved workforce utilisation. The demonstration is persuasive, particularly because the provider operates across several rural communities where travel costs and continuity are persistent pressures.

Rather than purchasing immediately, the operations director agrees a controlled evaluation involving two localities. The provider establishes its existing performance using visit punctuality, travel distances, missed and shortened visits, care worker feedback, rota changes and continuity of support. People receiving care are asked whether visit timing, familiarity and reliability reflect their preferences.

During the pilot, the proposed system produces more efficient travel routes. However, its initial optimisation also increases the number of different care workers visiting some people. One person living with dementia becomes unsettled by unfamiliar faces, while another explains that an earlier visit is less helpful because it disrupts a valued morning routine.

The Registered Manager works with the supplier to adjust scheduling priorities so that continuity, preferred visit windows and essential worker competencies receive greater weight. The provider then compares the revised schedules with the baseline, examining both operational efficiency and people's experiences.

The final investment decision is supported by a more nuanced business case. Travel efficiency improves, but the provider rejects a proposed staffing reduction because the evidence does not demonstrate that it would preserve safe, personalised support. The contract includes agreed configuration requirements, implementation support and performance review arrangements.

This illustrates why homecare workforce scheduling cannot be evaluated through mileage and productivity alone. The purchasing decision is stronger because it tests the relationship between efficiency, workforce conditions and continuity rather than assuming those outcomes automatically reinforce one another.

Supplier Due Diligence: Financial Stability, Security and Service Dependence

Supplier assurance extends beyond product functionality. A provider may depend on a digital supplier to maintain access to care records, deliver urgent updates, support medicines documentation or enable communication between geographically dispersed teams. That dependence creates operational exposure if the supplier experiences financial difficulty, service disruption, a cyber incident or a change in commercial ownership.

Due diligence should therefore be proportionate to the importance of the technology. A standalone administrative application may warrant a different level of scrutiny from a platform containing sensitive care records or supporting time-critical decisions. The provider's assessment should consider the consequences of failure, not simply the supplier's size or reputation.

Information security assurances, independent certifications and penetration-testing summaries can provide useful evidence, but they do not remove the need to understand the actual service. Providers should establish where information is stored, who can access it, how subcontractors are involved, how incidents are reported and how quickly essential services can be restored.

Financial resilience also matters. Smaller specialist suppliers can offer valuable innovation and responsiveness, but providers should understand how support, development and access to information would be maintained if the supplier ceased trading. Large suppliers are not immune to disruption, product withdrawal or changes in commercial priorities.

These considerations connect digital purchasing with supply-chain resilience and cybersecurity and digital continuity. A credible contract should address service levels, incident communication, data access, restoration arrangements, subcontracting and exit assistance.

Crucially, the provider should test its own contingency arrangements. If the platform becomes unavailable during an evening shift, can staff identify essential support requirements, administer medicines safely where applicable and record urgent changes? A supplier's recovery commitment is only one part of the provider's business continuity responsibilities.

Data Protection, Consent and the Boundaries of Digital Monitoring

Adult social care technology frequently processes highly sensitive information concerning health, disability, personal circumstances and support needs. Procurement therefore needs early information governance involvement rather than treating privacy as a contractual detail to resolve after the supplier has been selected.

Under UK data protection law, organisations need an appropriate lawful basis for processing personal information and an additional condition where special category data is involved. The applicable arrangements depend on the purpose, the organisations involved and their respective responsibilities. Consent to receive care, consent to a particular intervention and consent as a lawful basis for data processing are distinct questions.

Providers should establish whether the supplier acts as a processor, an independent controller or in another arrangement, and ensure that contracts reflect the actual processing relationship. Data protection impact assessments are required where processing is likely to result in high risk to individuals' rights and freedoms. They are particularly relevant to certain forms of monitoring, profiling and innovative processing involving vulnerable people.

Procurement decisions should also consider accessibility and the risk of excessive surveillance. A monitoring system might provide useful reassurance about falls or night-time safety while also collecting more information than is necessary. A person may prefer a less intrusive approach, even where the more comprehensive system offers greater management visibility.

The Mental Capacity Act 2005 provides the relevant decision-making framework in England and Wales where a person may lack capacity for a specific decision. Capacity is decision-specific, and people should receive practicable support to make their own decisions. Where a best-interests decision is necessary, the relevant legal requirements apply; purchasing technology does not itself justify intrusive monitoring or restrictions.

Meaningful co-production, choice and control require providers to consider how people understand the technology, what alternatives exist and whether arrangements can be adapted or withdrawn. Families and advocates may contribute important perspectives, but their involvement should respect the person's wishes, confidentiality and legal decision-making framework.

Scenario: Assistive Technology in Supported Living Without Unnecessary Surveillance

A supported living provider is approached by a supplier offering movement sensors and automated overnight alerts. The technology could help staff identify situations requiring support while reducing unnecessary checks that interrupt people's sleep. The supplier presents evidence from residential settings, but the provider recognises that supported living involves distinct expectations concerning tenancy, privacy and individual control.

One tenant, who has a learning disability and communicates using a combination of speech and visual information, is interested in having fewer overnight interruptions. Another person strongly dislikes the idea of sensors in their home. The provider does not treat the technology as a uniform service-wide requirement.

Working with the people concerned, their chosen supporters and relevant professionals, the team explores which risks the technology might address and whether less intrusive alternatives are available. Accessible demonstrations allow tenants to understand what information would be collected, who could see it and what would happen when an alert was generated.

A limited trial is agreed for the person who wishes to proceed, with appropriate consent and decision-making arrangements. Staff monitor false alerts, response times, sleep disturbance and whether the person feels more in control. The provider also tests what happens when connectivity fails and confirms that the technology will not substitute for support required by assessed needs.

The trial identifies a useful reduction in unnecessary disturbance, but the supplier's original alert thresholds generate excessive notifications. Following adjustment, the person reports better sleep and greater satisfaction. The other tenant continues with their preferred support arrangements.

The procurement decision is consequently based on individual benefit rather than blanket deployment. The provider can demonstrate how assistive technology supports independence while protecting privacy, recognising that a product's technical capability does not establish its suitability for every person.

Workforce Readiness and the Hidden Cost of Implementation

Technology procurement frequently underestimates the practical work required to change established routines. Staff may be expected to adopt new recording methods while continuing to deliver time-sensitive support. Registered Managers may need to oversee migration, training, incident management and supplier engagement without additional operational capacity.

Successful implementation depends on more than completing supplier-led training. Staff need to understand why the system is being introduced, how it affects their responsibilities and what to do when information is incomplete, an alert appears unreliable or the system becomes unavailable.

Digital confidence also varies. Some workers may adapt quickly, while others require supported practice, accessible guidance or additional time. Language, disability, device availability and working patterns can affect participation. Training arrangements should therefore reflect the workforce rather than assume that a standard online module will establish competence.

Providers can strengthen digital skills and workforce adoption through practical observation, supervised use, scenario-based exercises and feedback from staff working across different shifts. Competence is demonstrated when workers can use the technology appropriately in real situations, including recognising its limitations.

The introduction of digital records may also reveal previously hidden problems. Inconsistent terminology, incomplete care plans or poor handovers can become more visible when information is standardised. These findings should not automatically be interpreted as technology failure. They may provide an opportunity to improve underlying practice, provided managers have sufficient capacity to respond.

Procurement appraisal should include the effect on staff wellbeing and professional judgement. A system that increases alerts, duplicate entries or perceived surveillance may create additional pressure even when it produces attractive management reports. Workforce feedback during piloting and after deployment is therefore part of investment assurance, not simply a measure of staff satisfaction.

Interoperability, Data Portability and the Risk of Supplier Lock-In

Care providers rarely operate a single digital system. They may use separate platforms for care records, rotas, medicines, recruitment, payroll, quality monitoring and financial management. Information may also need to move between providers, local authorities, NHS organisations and housing partners.

A product that performs well independently can become problematic if staff must repeatedly enter the same information or manually reconcile inconsistent records. These weaknesses can increase administrative burden and create uncertainty about which record is authoritative.

Interoperability should therefore be examined during procurement rather than treated as a future enhancement. Suppliers should explain which integrations are currently operational, which depend on additional development, what technical standards are supported and who will maintain connections when systems change.

Providers should distinguish between a demonstrated integration and a supplier's intention to develop one. They should also understand whether additional charges apply and how responsibilities are divided when information fails to transfer correctly.

Equally important is the ability to leave. A provider that cannot extract complete, usable records without substantial expense may become commercially dependent on a supplier regardless of future performance. Contractual arrangements should specify data export, formats, retention, deletion, transition support and the treatment of information following termination, subject to applicable legal obligations.

These are central questions within interoperability and system integration. Strong procurement does not require every provider to build an elaborate technical architecture, but it should protect essential information and avoid unnecessary barriers to future service development.

Scenario: An Extra Care Provider Challenges an AI Supplier's Performance Claims

An extra care housing provider is considering an artificial intelligence product that analyses digital care records and highlights possible changes in people's needs. The supplier claims that its system can identify deterioration earlier, reduce avoidable incidents and help managers allocate resources more effectively.

The provider's quality director recognises the potential benefit but asks how the claims have been validated. The supplier's published results come from a limited evaluation in a different care environment. Although promising, they do not establish how accurately the product will interpret records written by the provider's own workforce.

A supervised pilot is designed around retrospective, appropriately governed data and a limited prospective evaluation. Staff and clinical partners examine whether alerts identify meaningful changes, how often they generate false positives and whether important concerns are missed. The provider also considers whether records from people with different communication needs are interpreted consistently.

Early testing reveals that the system sometimes treats routine changes in activity as indicators of deterioration. It also struggles to distinguish a person's established preferences from unexpected changes. Rather than allowing automated alerts to trigger care-plan amendments, the provider requires professional review and clear escalation arrangements.

People receiving support and their representatives are involved in discussing acceptable uses of their information and the consequences of automated monitoring. The quality team records the pilot's limitations alongside its benefits, including the additional work created by reviewing alerts.

The board authorises a further restricted evaluation rather than full deployment. Its decision is supported by evidence that the technology may assist professional assessment, but not yet by sufficient evidence of improved outcomes or a sustainable return on investment.

This approach to artificial intelligence and automation in care recognises that supplier innovation can be valuable without treating predictive claims as established clinical or operational facts.

Contract Design: Making Supplier Accountability Meaningful

Evidence-based procurement should influence the contract itself. If a supplier's proposal promises specific capabilities, support arrangements or implementation benefits, the purchaser needs clarity about which commitments are contractually enforceable and how performance will be assessed.

Contractual service levels commonly address availability, response times and technical support. These are necessary but may be insufficient for systems that affect frontline care. A platform could meet its uptime target while providing unreliable integrations, generating excessive alerts or failing to support the workflows for which it was purchased.

Providers should therefore distinguish between technical service performance and the operational results they expect to achieve. The supplier can reasonably be held accountable for matters within its control, such as functionality, support, security commitments and agreed implementation services. The provider remains responsible for workforce deployment, care practice and many of the wider conditions affecting outcomes.

Contracts can establish arrangements for acceptance testing, implementation milestones, defect resolution, changes in functionality, service reviews and escalation. They should also address the consequences of serious underperformance, including remediation, termination and transition where appropriate.

Not every outcome can fairly be guaranteed by a supplier. A reduction in safeguarding incidents, for example, depends on many organisational and individual factors. However, the supplier should be able to explain how its technology supports relevant controls, what evidence underpins its claims and how the purchaser can evaluate performance.

Where procurement is connected to a commissioned service, providers may need to align supplier commitments with their own obligations to commissioners. The Commissioner Evidence Builder offers a practical way to structure evidence concerning service commitments, performance, outcomes and assurance, helping providers distinguish between what a supplier promises and what the commissioned service can demonstrate.

Scenario: A Local Authority Evaluates a Shared Digital Care Platform

A local authority is exploring whether a shared digital reporting platform could improve oversight of commissioned homecare services. Its existing arrangements require providers to submit performance information in different formats, creating duplication and limiting the authority's ability to identify emerging capacity pressures.

The proposed platform promises more consistent information and faster reporting. However, the commissioning team recognises that providers vary considerably in size, digital capability and available administrative resources. A system that works well for a large regional organisation may impose disproportionate costs on a small community provider.

Before finalising the procurement specification, the authority engages providers, people receiving support and relevant information governance specialists. Discussions identify a need for accessible reporting, clear definitions of performance measures and proportionate requirements for smaller organisations. Providers also explain that some proposed measures could create misleading comparisons between services supporting people with very different needs.

The authority revises its requirements to distinguish essential information from optional reporting features. Evaluation considers security, interoperability, accessibility, implementation support, total cost and the quality of supplier evidence. A limited rollout allows reporting definitions and technical connections to be tested before wider adoption.

During implementation, the authority discovers that differences in how providers record missed visits affect the apparent performance comparisons. It works with providers to improve definitions and validation rather than treating the initial dashboard as an authoritative ranking.

The resulting investment strengthens contract monitoring while preserving room for professional interpretation and provider dialogue. It also demonstrates how procurement can support market sustainability when commissioners understand the practical costs of compliance.

For both purchasers and providers, technology and digital innovation in tenders are most credible when specifications and evaluation criteria connect measurable capability with realistic service delivery.

Post-Implementation Assurance: Did the Investment Deliver?

Procurement governance should not end when a system goes live. Implementation completion demonstrates that a product has been introduced; it does not establish whether the original investment objectives have been achieved.

A meaningful review compares actual performance with the baseline and assumptions used to justify purchasing. It should examine whether benefits have emerged, whether unexpected costs have developed and whether the technology has changed how people experience support.

Evaluation should distinguish between several levels of evidence:

• Deployment: whether the system is available, configured and being used as intended.
• Practice: whether recording, communication, decision-making or responses have improved.
• Outcomes: whether people experience greater safety, independence, choice, continuity or wellbeing.
• Sustainability: whether improvements continue without disproportionate cost, workload or risk.

These levels are connected but should not be confused. High adoption can coexist with poor outcomes, and an early improvement may disappear when temporary project support ends.

Leadership teams can use the Quality Dashboard Builder to structure performance and outcome reporting, bringing together operational indicators, exceptions and improvement measures. Its usefulness depends on selecting meaningful indicators and validating the underlying information.

Evidence should also include people's accounts of their experiences, staff observations, complaints, incidents and direct checks of practice. Where results differ between services or groups, leaders should examine whether the variation reflects differences in needs, implementation, access or system design.

Within digital audit and assurance, the strongest approach is not to produce more reports automatically. It is to use trustworthy information to decide whether the investment should be maintained, adapted, expanded or reconsidered.

Board Oversight, Investment Decisions and Organisational Learning

Boards and trustees need assurance that major technology investments are consistent with organisational purpose, financial capacity and the provider's responsibilities towards people receiving support. That requires a decision-making process in which risks, alternatives and evidence are visible before significant commitments are made.

Responsibility will differ according to organisational size. A small provider may combine several functions within a limited leadership team, while a larger group may involve procurement specialists, digital leads, information governance officers, operational directors and board committees. In either case, decision-making authority and escalation routes should be understood.

A board's scrutiny should extend beyond whether the project remains within budget. It should consider whether the technology is delivering the intended benefit, whether frontline risks are being managed and whether contractual dependence is becoming excessive.

The Governance Maturity Assessment can support a structured examination of accountability, risk ownership and assurance arrangements surrounding significant organisational decisions.

For mature providers, procurement learning should influence future investment. If a supplier's promised savings did not materialise, leaders should establish whether the assumptions were unrealistic, implementation was inadequate or external conditions changed. If a pilot succeeded in one service but not another, the differences should inform subsequent decisions.

This approach strengthens board assurance and effectiveness because investment decisions become part of a continuing cycle of evidence, challenge and organisational learning rather than isolated approvals.

How Technology Procurement May Evolve Over the Next Five Years

The direction of technology procurement in adult social care is likely to be influenced by several connected developments: increasing use of digital records, pressure for better interoperability, greater attention to cyber resilience and growing interest in AI-supported operational analysis. None guarantees that procurement will become more effective. Much will depend on purchasers' ability to evaluate evidence and maintain meaningful oversight.

One plausible development is a shift towards more structured outcome-based evaluation. Rather than relying primarily on functionality demonstrations, purchasers may increasingly require suppliers to explain the evidence behind claimed benefits, support controlled pilots and provide information that enables independent assessment.

AI procurement may require particularly careful scrutiny. Providers will need to understand what a system actually does, how it has been tested, where errors may arise and which decisions remain subject to human judgement. Emerging agentic systems capable of initiating actions across multiple platforms could create additional requirements for permissions, audit trails, human authorisation and recovery from unintended actions.

Another development may be greater emphasis on portability and open integration. Providers and commissioners have an interest in reducing avoidable duplication and preventing essential information from becoming inaccessible when suppliers change. Achieving this will require commercial cooperation, technical standards and sustained investment rather than procurement wording alone.

Environmental sustainability and digital inclusion may also receive greater attention. Device replacement cycles, energy consumption, accessibility and the practical consequences of excluding people who cannot or do not wish to use digital interfaces should form part of proportionate appraisal.

The most significant change, however, may be cultural. Technology procurement could increasingly resemble a continuous quality-improvement decision: identify a meaningful need, test the proposed response, examine its effects, learn from implementation and reconsider investment when the evidence changes.

That would represent a more substantial transformation than simply adopting newer products. It would make procurement more closely aligned with care outcomes, organisational resilience and the responsible use of limited resources.

Conclusion

The future of technology procurement in adult social care will not be determined solely by faster software, more sophisticated AI or the number of systems organisations adopt. It will depend on whether providers and commissioners become more discerning purchasers, capable of separating supplier claims from credible evidence and technical capability from meaningful improvement.

For providers, this means understanding the operational problem before selecting a product, examining whole-life costs and testing whether technology supports safe, personalised care. It also means involving people receiving support and frontline workers in decisions that affect their daily lives, rather than assuming that efficiency gains necessarily translate into better experiences.

For commissioners, stronger procurement can support transparency, proportionate assurance and market sustainability. For Registered Managers and operational leaders, it can reduce the risk of introducing systems that create additional workload or obscure professional judgement. For boards, it provides a stronger basis for challenging investment assumptions and reviewing whether promised benefits have been realised.

Evidence-based investment does not eliminate uncertainty. Technology, service needs, workforce conditions and regulatory expectations will continue to change. What it offers is a more disciplined way of making decisions, acknowledging limitations and learning from results.

Ultimately, the measure of a successful digital purchase is not the sophistication of the supplier's demonstration or the apparent completeness of the contract. It is whether the technology becomes a reliable, proportionate and sustainable part of better care, with benefits that can be demonstrated in the lives of the people it is intended to support.